JOHNSON & JOHNSON Current Liabilities 2008-2026 | JNJ
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is JOHNSON & JOHNSON's current current liabilities?
JOHNSON & JOHNSON (JNJ) annual current liabilities for 2025 was $54.13B, a 7.56% increase from 2024. JOHNSON & JOHNSON current liabilities for the quarter ending March 29, 2026 was $57.72B.
What was JOHNSON & JOHNSON's current liabilities in 2024?
JOHNSON & JOHNSON annual current liabilities for 2024 was $50.32B, a 8.73% increase from 2023.
What was JOHNSON & JOHNSON's current liabilities in 2023?
JOHNSON & JOHNSON annual current liabilities for 2023 was $46.28B, a 2.33% increase from 2022.
What is JOHNSON & JOHNSON's 4-year current liabilities CAGR?
JOHNSON & JOHNSON current liabilities grew at a compound annual growth rate (CAGR) of 6.24% from FY2021 to FY2025, going from $42.49B to $54.13B over 4 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+8.5%
FY2019
$35.96B
→
FY2025
$54.13B
081011121314161718192122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $54.13B | +7.6% | 10-K |
| FY2024 | $50.32B | +8.7% | 10-K |
| FY2023 | $46.28B | +2.3% | 10-K |
| FY2022 | $45.23B | +6.4% | 10-K |
| FY2021 | $42.49B | +18.2% | 10-K |
| FY2019 | $35.96B | +15.2% | 10-K |
| FY2018 | $31.23B | +2.3% | 10-K |
| FY2017 | $30.54B | +10.1% | 10-K |
| FY2016 | $27.75B | +10.9% | 10-K |
| FY2014 | $25.03B | -2.5% | 10-K |
| FY2013 | $25.68B | +5.8% | 10-K |
| FY2012 | $24.26B | +5.2% | 10-K |
| FY2011 | $23.07B | +6.2% | 10-K |
| FY2010 | $21.73B | +4.2% | 10-K |
| FY2008 | $20.85B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →